Date Filed | Type | Description |
06/12/2023 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns:
| Granted 8,584 shares
@ $0 Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
05/17/2023 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 3,620 restricted stock units
@ $0 |
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/02/2020 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 371 restricted stock units
@ $0 |
|
08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2020 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns:
| Granted 5,855 shares
@ $0 Granted 18,574 options to buy
@ $12.81, valued at
$237.9k
|
|
05/26/2020 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 2,446 restricted stock units
@ $0 |
|
05/01/2020 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 473 restricted stock units
@ $0 |
|
03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2019 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 503 restricted stock units
@ $0 |
|
07/01/2019 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns:
| Granted 6,250 shares
@ $0 Granted 19,473 options to buy
@ $12, valued at
$233.7k
|
|
05/24/2019 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Exercised 1,970 restricted stock units
@ $0 |
|
05/23/2019 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 2,604 restricted stock units
@ $0 |
|
09/11/2018 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on AMICUS THERAPEUTICS INC
Txns:
| Granted 9,600 shares
@ $0 Granted 14,605 options to buy
@ $12.5, valued at
$182.6k
|
|
05/25/2018 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 1,970 restricted stock units
@ $0 |
|
05/02/2018 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 170 restricted stock units
@ $0 |
|
04/18/2018 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on DST SYSTEMS INC
Txns:
| Disposed/sold 8,316 shares
@ $84, valued at
$698.5k
Disposed/sold 7,672 shares
@ $84, valued at
$644.4k
|
|
02/01/2018 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 132 restricted stock units
@ $0 |
|
12/12/2017 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on DST SYSTEMS INC
Txns:
| Granted 22 shares
@ $0 |
|
11/02/2017 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on STERICYCLE INC
Txns:
| Granted 141 restricted stock units
@ $0 |
|
09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/11/2017 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on DST SYSTEMS INC
Txns:
| Granted 1,840 shares
@ $125.005, valued at
$230k
|
|
03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|